CONCLUSIONS	Exenatide QW was statistically noninferior to insulin glargine for the change in HbA ( 1c ) from baseline to end point ; these results suggest that exenatide QW may provide an effective alternative treatment for Japanese patients who require additional therapy to control their diabetes .\